| Pigmentary Glaucoma Treatment | Ali Ekrem AYDIN | 201–205 |
| Assessing Corneal Changes in Age-Related Macular Degeneration | Mehmet B COSKUN | 206–209 |
| The Assessment of The Effect of Cycloplegia on Biometric Measurements in Various Age Groups | Ayse CICEK,Esra VURAL,Bedirhan ALABAY,Ender SIRAKAYA,Hayrettin COBANOGLU,Muhammed Raşit SIREM,Sefa UNAL | 210–215 |
| 2-Year Follow-up Results in XEN Glaucoma Implant Patients | Yusuf AYAZ,Elif Betul TURKOGLU,Berkay Oner KARACA,Iclal YUCEL,Mustafa UNAL | 216–220 |
| Anterior Segment Parameters and Axial Length Value in Emmetropic Eyes in Different Age Groups | Ali KELES,Eren EKICI,Mehmet CITIRIK,Mustafa KOC,Mehmethan DOGAN,Suleyman Korhan KARAMAN | 221–224 |
| Our Combined Phacotrabeculectomy and Post-phacotrabeculectomy Laser Suture Lysis Results | Caglar OKTEM,Umit EKSIOGLU,Ahmet KADERLI,Mehmet YAKIN,Gulizar DEMIROK,Firdevs ORNEK | 225–230 |
| The Effect of Exfoliation on Surgically Induced Astigmatism in Patients After Trabeculectomy | Mehmet Murat UZEL,Ufuk ELGIN,Mert SIMSEK | 231–235 |
| Preoperative Intracameral and Intravitreal Afl ibercept Injection, Pars Plana Vitrectomy and Ahmed Glaucoma Valve Implantation in Refractory Neovascular Glaucoma | Alper Can YILMAZ,Bagim Aycin CAKIR,Mehmet Talay KOYLU,Murat KUCUKEVCILIOGLU | 236–239 |
| Cerebrotendinous Xanthomatosis as a Very Rare and Treatable Disease Frequently Overlooked: A Case Series | Zeliha KARADEMIR,Hasan ONAL | 240–243 |